Cite
Reduction in Cardiac Mortality With Bivalirudin in Patients With and Without Major Bleeding: The HORIZONS-AMI Trial (Harmonizing Outcomes with Revascularization and Stents in Acute Myocardial Infarction).
MLA
Stone, Gregg W., et al. “Reduction in Cardiac Mortality With Bivalirudin in Patients With and Without Major Bleeding: The HORIZONS-AMI Trial (Harmonizing Outcomes with Revascularization and Stents in Acute Myocardial Infarction).” Journal of the American College of Cardiology (JACC), vol. 63, no. 1, Jan. 2014, pp. 15–20. EBSCOhost, https://doi.org/10.1016/j.jacc.2013.09.027.
APA
Stone, G. W., Clayton, T., Deliargyris, E. N., Prats, J., Mehran, R., & Pocock, S. J. (2014). Reduction in Cardiac Mortality With Bivalirudin in Patients With and Without Major Bleeding: The HORIZONS-AMI Trial (Harmonizing Outcomes with Revascularization and Stents in Acute Myocardial Infarction). Journal of the American College of Cardiology (JACC), 63(1), 15–20. https://doi.org/10.1016/j.jacc.2013.09.027
Chicago
Stone, Gregg W., Tim Clayton, Efthymios N. Deliargyris, Jayne Prats, Roxana Mehran, and Stuart J. Pocock. 2014. “Reduction in Cardiac Mortality With Bivalirudin in Patients With and Without Major Bleeding: The HORIZONS-AMI Trial (Harmonizing Outcomes with Revascularization and Stents in Acute Myocardial Infarction).” Journal of the American College of Cardiology (JACC) 63 (1): 15–20. doi:10.1016/j.jacc.2013.09.027.